Cicatrix Clinical Trial
Official title:
A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Improvement of Scar Appearance in Patients Undergoing Bilateral Reduction Mammaplasty.
Severe scarring is a common problem following breast reduction surgery, studies have shown
that over 64% of patients develop a hypertrophic scar at three months after the operation.
Scar severity can be influenced by a large number of factors including age, sex, skin
thickness and tension, ethnicity and the position of the scar on the body. Therefore the
most sensitive and reliable method to assess the efficacy of an anti-scarring treatment is
to compare bilateral wounds on the same individual. Bilateral breast reduction surgery
provides an ideal model for a within patient evaluation of anti-scarring activity in wounds
which develop into bad scars.
This study is being undertaken to investigate the efficacy and safety of Juvista (given as
an intradermal injection of 200ng per 1cm wound margin) in the reduction of scar appearance
applied to approximated wound margins following bilateral reduction mammaplasty.
Status | Terminated |
Enrollment | 39 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Female patients between 18 and 65 years of age undergoing bilateral reduction mammaplasty with anchor shaped incisions, who have given written informed consent. - Patients with a Body Mass Index of 15-32 kg/m2 inclusive. - Patients of child bearing potential who are using method(s) of contraception acceptable to the Investigator and agree to do so from at least the screening visit until 1 month after administration of the trial investigational products. - Patients with, in the opinion of the Investigator, clinically acceptable results for the laboratory tests specified in the trial protocol. Exclusion Criteria: - Patients with significant breast asymmetry that may result in asymmetrical operative incisions being made on the left and rights breasts. - Patients with breast asymmetry that may result in different post-operative tensions on the wounds of the left and right breasts. - Patients who have had surgery in the area to be incised within one year of trial surgery. - Patients with a history of a bleeding disorder. - Patients with a history of breast malignancy. - Patients with a skin disorder that is chronic or currently active and which the Investigator considers will adversely affect the healing of the wounds or involves the areas to be examined in this trial. - Patients who on direct questioning and/or physical examination, have evidence of any past or present clinically significant medical condition that would impair wound healing. - Patients with a history of clinically significant hypersensitivity to any of the drugs or surgical dressings to be used in this trial. - Patients who are taking, or have taken, any investigational drugs in the 3 months prior to the screening visit. - Patients who are taking regular, continuous, oral corticosteroid therapy. - Patients undergoing investigations or changes in management for an existing medical condition. - Patients who are or who become pregnant up to and including the day of surgery or who are lactating. - Patients with diseases or conditions that could, in the opinion of the Investigator, interfere with the assessment of safety or efficacy of the investigational product. - Patients who, in the opinion of the Investigator, are not likely to complete the trial. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United Kingdom | Fitzwilliam Clinic | Belfast | |
United Kingdom | Selly Oak Hospital | Birmingham | |
United Kingdom | Queen Victoria Hospital | East Grinstead | |
United Kingdom | Royal Victoria Infirmary | Newcastle Upon Tyne | |
United Kingdom | Royal Preston Hospital | Preston | |
United Kingdom | Odstock Centre for Burns & Plastic Surgery, Salisbury District Hospital | Salisbury |
Lead Sponsor | Collaborator |
---|---|
Renovo |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Investigator scar assessment | |||
Primary | Patient scar assessment | |||
Primary | Independent scar assessment | |||
Secondary | Local tolerance | |||
Secondary | Adverse events |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02672956 -
Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results
|
N/A | |
Completed |
NCT02645773 -
Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring
|
N/A | |
Completed |
NCT00629811 -
Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women
|
Phase 2 | |
Completed |
NCT00977951 -
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Completed |
NCT00847795 -
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03213548 -
Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty
|
N/A | |
Recruiting |
NCT05377723 -
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
|
N/A | |
Active, not recruiting |
NCT01976260 -
A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
|
N/A | |
Completed |
NCT00984503 -
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
|
Phase 2 | |
Completed |
NCT00594581 -
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
|
Phase 2 | |
Recruiting |
NCT04420442 -
Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars
|
N/A | |
Completed |
NCT02772289 -
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
|
Phase 2 | |
Completed |
NCT00430326 -
Juvista (Avotermin) in Scars Following Varicose Vein Removal
|
Phase 2 | |
Completed |
NCT00847925 -
Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT05787171 -
Three Sutures With Different Absorption Rates for Lower Abdominal Incision
|
N/A | |
Completed |
NCT02985151 -
Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy
|
N/A | |
Completed |
NCT02340325 -
FS2 Safety and Tolerability Study in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00432211 -
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
|
Phase 2 | |
Completed |
NCT00978302 -
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
|
Phase 1 | |
Withdrawn |
NCT04034615 -
The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
|
Phase 2 |